您所在的位置: 首页 --> 导师团队 --> 柯杨

导师基本信息

  • 姓名:柯杨
  • 性别:
  • 民族:汉族
  • 科室:遗传学研究室
  • 职称:研究员 ,教授
  • 专业:肿瘤学
  • E-MAIL: keyang@bjmu.edu.cn

学术论文 | 综述述评 | 奖励表彰 | 研究方向 | 科研项目 | 招生计划

He Zhonghu#, Liu Zhen#, Liu Mengfei#, Guo Chuanhai, Xu Ruiping, Li Fenglei, Liu Anxiang, Yang Haijun, Shen Lin, Wu Qi, Duan Liping, Li Xiang, Zhang Chaoting, Pan Yaqi, Cai Hong*, Ke Yang*. Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial. 2019;,Gut,68(2):198-206.

Liu Mengfei#, Liu Zhen#, Cai Hong, Guo Chuanhai, Li Xiang, Zhang Chaoting, Wang Hui, Hang Dong, Liu Fangfang, Deng Qiuju, Yang Xin, Yuan Wenqing, Pan Yaqi, Li Jingjing, Zhang Chanyuan, Shen Na, He Zhonghu*, Ke Yang*. A Model To Identify Individuals at High Risk for Esophageal Squamous Cell Carcinoma and Precancerous Lesions in Regions of High Prevalence in China.,Clin Gastroenterol Hepatol,15(10):1538-1546 e1537.

Li Jingjing#, Xu Ruiping#, Liu Mengfei#, Cai Hong, Cao Changqi, Liu Fangfang, Li Fenglei, Guo Chuanhai, Pan Yaqi, He Zhonghu*, Ke Yang*. Lugol Chromoendoscopy Detects Esophageal Dysplasia With Low Levels of Sensitivity in a High-Risk Region of China.,Clin Gastroenterol Hepatol,16(10):1585-1592.

Li Jingjing#, Yan Shi#, Liu Zhen#, Zhou Yong, Pan Yaqi, Yuan WenQin, Liu Mengfei, Tan Qin, Tian Geng, Dong Bin, Cai Hong, Wu Nan*, Ke Yang*. Multiregional Sequencing Reveals Genomic Alterations and Clonal Dynamics in Primary Malignant Melanoma of the Esophagus.,Cancer Res,78(2):338-347

Liu Mengfei#, Liu Fangfang#, Pan Yaqi#, He Zhonghu#, Guo Chuanhai, Zhang Chanyuan, Li Xiang, Hang Dong, Wang Qiyan, Liu Ying, Li Jingjing, Liu Zhen, Cai Hong, Ke Yang*. Viral Load in the Natural History of Human Papillomavirus Infection Among Men in Rural China: A Population-based Prospective Study.,Clin Infect Dis,67(12):1861-1867.

Tan Qin#, Ku Wenjing#, Zhang Chaoting, Heyilimu Palashati, Tian Yuan, Ke Yang*, Lu Zheming*. Mutation analysis of the EBV-lymphoblastoid cell line cautions their use as antigen-presenting cells.,Immunology and cell biology,96(2):204-211.

Wang Hui#, Cao Changqi#, Guo Chuanhai, He Yu, Li Fenglei, Xu Ruiping, Liu Mengfei, Liu Zhen, Pan Yaqi, Liu Fangfang, Liu Ying, Li Jingjing, Cai Hong, He Zhonghu*, Ke Yang*. An evaluation of EQ-5D-3L health utility scores using five country-specific tariffs in a rural population aged 45-69?years in Hua county, Henan province, China.,Health and quality of life outcomes,18(1):228

Li Fuxiao#, Li Xiang#, Guo Chuanhai, Xu Ruiping, Li Fenglei, Pan Yaqi, Liu Mengfei, Liu Zhen, Shi Chao, Wang Hui, Wang Minmin, Tian Hongrui, Liu Fangfang, Liu Ying, Li Jingjing, Cai Hong, Yang Li, He Zhonghu*, Ke Yang*. Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled Trial.,Pharmacoeconomics,37(6):819-827.

Liu Mengfei#, He Zhonghu#, Guo Chuanhai, Xu Ruiping, Li Fenglei, Ning Tao, Pan Yaqi, Li Yong, Ding Huirong, Zheng Li, Zhou Yue, Tian Xiuyun, Yang Wenjun, Wang Xueqian, Lu Fang, Zhang Yanyan, Zhao Yiqiang, Guo Fangcen, Chen Ke, Gao Lei, Sun Min, Liu Ying, Liu Fangfang, Hang Dong, Shen Na, Li Jingjing, Xu Zhongyao, Wang Qiyan, Zhang Chanyuan, Abliz Amir, Deng Qiuju, Li Xiang, Liu Zhen, Zhang Chaoting, Yuan Wenqing, Wang Hui, Weiss Noel S*, Cai Hong*, Ke Yang*. Effectiveness of Intensive Endoscopic Screening for Esophageal Cancer in China: A Community-Based Study. . 2019;,Am J Epidemiol,188(4):776-784.

Shi Chao#, Liu Mengfei#, Liu Zhen, Guo Chuanhai, Li Fenglei, Xu Ruiping, Liu Fangfang, Liu Ying, Li Jingjing, Cai Hong, He Zhonghu*, Ke Yang*. Using health insurance reimbursement data to identify incident cancer cases.,J Clin Epidemiol,114:141-149.

Tan Qin, Zhang Chaoting*, Yang Wenjun, Liu Ying, Heyilimu Palashati, Feng Dongdong, Xing Liying, Ke Yang*, Lu Zheming*. Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma.,J Immunother Cancer,7(1):232.

Yuan Wenqing#, Liu Zhen#, Wang Yu, Liu Mengfei, Pan Yaqi, Lei Wanjun, Yang Haijun, Xu Ruiping, Zhang Lixin, Cai Hong, Li Jun, Ke Yang*. Clonal evolution of esophageal squamous cell carcinoma from normal mucosa to primary tumor and metastases.,Carcinogenesis,40(12):1445-1451

He Zhonghu, Ke Yang*. Precision screening for esophageal squamous cell carcinoma in China.,Chinese journal of cancer research,32(6):673-682.

Liu Mengfei#, Liu Zhen#, Liu Fangfang#, Guo Chuanhai, Xu Ruiping, Li Fenglei, Liu Anxiang, Yang Haijun, Zhang Sanshen, Shen Lin, Duan Liping, Wu Qi, Cao Changqi, Pan Yaqi, Liu Ying, Li Jingjing, Cai Hong, He Zhonghu*, Ke Yang*. Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in China.,Clin Gastroenterol Hepatol,18(7):1626-1635 e1627

He Zhonghu#, Liu Zhen#, Liu Mengfei#, Guo Chuanhai, Xu Ruiping, Li Fenglei, Liu Anxiang, Yang Haijun, Shen Lin, Wu Qi, Duan Liping, Li Xiang, Zhang Chaoting, Pan Yaqi, Cai Hong*, Ke Yang*. Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial.,Gut,68(2):198-206.

Liu Mengfei#, Zhou Ren#, Guo Chuanhai, Xu Ruiping, Liu Anxiang, Yang Haijun, Li Fenglei, Duan Liping, Shen Lin, Wu Qi, Liu Zhen, Liu Fangfang, Liu Ying, Pan Yaqi, Cai Hong, Weiss Noel S*, He Zhonghu*, Ke Yang*. Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus. Gastrointest Endosc. 2020.,Gastrointest Endosc,18;S0016-5107(20)34785-4

Liu Zhen#, Guo Chuanhai#, He Yujie#, Chen Yun#, Ji Ping#, Fang Zhengyu#, Li Fenglei, Tang Yuefei, Chen Xiujian, Xiao Ping, Wang Chengwen, Yin Weihua, Guo Hai, Liu Mengfei, Pan Yaqi, Liu Fangfang, Liu Ying, He Zhonghu*, Ke Yang*. A clinical model predicting the risk of esophageal high-grade lesions in opportunistic screening: a multicenter real-world study in China,Gastrointest Endosc,91(6):1253-1260.e1253

Tian Hongrui#, Yang Wei#, Hu Yanjun#, Liu Zhen#, Chen Lei, Lei Liang, Zhang Fan, Cai Fen, Xu Huawen, Liu Mengfei, Guo Chuanhai, Chen Yun, Xiao Ping, Chen Junhui, Ji Ping, Fang Zhengyu, Liu Fangfang, Liu Ying, Pan Yaqi, Dos-Santos-Silva Isabel, He Zhonghu*, Ke Yang*. Estimating cancer incidence based on claims data from medical insurance systems in two areas lacking cancer registries in China.,EClinicalMedicine,20:100312.

He Z, Ke Y. Precision screening for esophageal squamous cell carcinoma in China.,China. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu,32(6): 673-82

北京大学2017年国华杰出学者奖, 北京大学国华杰出学者奖, 第1完成人 , 北京大学, 2017.12

基于临床的上消化道肿瘤预后预测研究, 课题负责人 , 2021.1.1~2021.12.31, 院内基金

基于“医保”及“死因监测”大数据构建恶性肿瘤多维度监测体系, 课题负责人 , 2020.11.1~2022.12.31, 横向课题——泰康

食管癌精准防治策略与大数据应用研究, 课题负责人 , 2019.6.1~2025.5.31, 横向课题——北医

基于临床的食管鳞癌风险预测模型构建与验证研究, 课题负责人 , 2017.1.1~2021.12.31, 深圳市政府“三名工程”

磁控胶囊内镜在上消化道检查中的临床应用研究, 课题负责人 , 2017.3.1~2017.12.31, 横向科研课题

中国安阳食管癌遗传变异的亚克隆进化和突变印迹研究, 课题负责人 , 2015.1.1~2017.12.31, 北京大学医学部—密歇根大学医学院“转化医学与临床研究联合研究所”国际合作项目/BMU20140483

食管鳞状细胞癌肿瘤异质性和临床结局的关联研究, 课题负责人 , 2014.9.1~2017.9.30, 北京市科委首都市民健康项目培育/Z141100002114046

研究生招生计划
招生年度 招生专业 学位级别 学位类型 研究方向 选拔方式
2022 肿瘤学 博士 科学学位 食管癌病因学及精准防治策略研究 申请考核制

社会任职

  • 《北京大学学报(医学版)》、《肿瘤研究与临床》副主编
  • Carcinogenesis、《中华肿瘤杂志》编委
  • 中国高等教育学会医学教育专业委员会第五届理事会会长
  • 临床医学专业学位副主任
  • 中华医学会副会长

学习、工作经历

  • 2014.10.1~,美国医学科学院外籍院士
  • 2004.12.31~2014.6.30,北京大学党委常委、常务副校长、医学部常务副主任
  • 2004.6.1~2004.12.31,北京大学副校长、医学部常务副主任
  • 2003.6.1~2004.6.1,北京大学医学部常务副主任
  • 2003.1.1~2005.12.31,北京大学副教务长